Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes

Human metapneumovirus (HMPV) is a leading cause of acute respiratory tract infections in infants and children. Currently, no approved HMPV vaccine is available. We developed a novel recombinant influenza virus, which carried partial HMPV F protein (HMPV-F) epitopes, utilizing reverse genetics. The n...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fang Sun, Guanglin Lei, Chongyu Tian, Zhifang Bai, Changqing Bai, Yufeng Li, Zhuoya Deng, Hao Yang, Cong Li, Zhongpeng Zhao, Yan Niu, Penghui Yang
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2024-12-01
Col·lecció:	Virulence
Matèries:	Influenza virus reverse genetics HMPV HMPV vaccine
Accés en línia:	https://www.tandfonline.com/doi/10.1080/21505594.2023.2284515
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!